0001104659-22-030178.txt : 20220303
0001104659-22-030178.hdr.sgml : 20220303
20220303191753
ACCESSION NUMBER: 0001104659-22-030178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Komjathy Andrew
CENTRAL INDEX KEY: 0001788465
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 22711293
MAIL ADDRESS:
STREET 1: CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astria Therapeutics, Inc.
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090127
4
1
tm228319-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-01
0
0001454789
Astria Therapeutics, Inc.
ATXS
0001788465
Komjathy Andrew
C/O ASTRIA THERAPEUTICS, INC.
100 HIGH STREET, FLOOR 28
BOSTON
MA
02110
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
6.51
2022-03-01
4
A
0
55000
0
A
Common Stock
55000
55000
D
This option was granted on March 1, 2022 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Jill C. Milne, as attorney-in-fact for Andrew Komjathy
2022-03-03